Evidence map›Paper›PMID 41169472›Full record

ArticleFrontiers in endocrinology2025

Association between atherogenic index of plasma and new onset of type 2 diabetes among elderly in China: a longitudinal study.

Xiang-Yang He, Zhi-Wei Lu, Yan-Fang Guo, Ren-Cheng Zhao, Zheng Liu

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiang-Yang HeDepartment of Health Management, Shenzhen Baoan District Chronic Diseases Prevent and Cure Hospital, Shenzhen, Guangdong, China.
Zhi-Wei LuDepartment of Health Education, Guangdong Health Promotion and Education Center, Guangzhou, Guangdong, China.
Yan-Fang GuoDepartment of Health Management, Shenzhen Baoan District Chronic Diseases Prevent and Cure Hospital, Shenzhen, Guangdong, China.
Ren-Cheng ZhaoDepartment of Health Management, Shenzhen Baoan District Chronic Diseases Prevent and Cure Hospital, Shenzhen, Guangdong, China.
Zheng LiuDepartment of Health Management, Shenzhen Baoan District Chronic Diseases Prevent and Cure Hospital, Shenzhen, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Previous studies have reported an association between the atherogenic index of plasma AIP and CVD incidence. However, few studies have investigated its longitudinal predictive effect on T2D among elderly individuals. Methods: Data from the BaHLS of the Community-Based Elderly Population in Shenzhen, China, were utilized. AIP was calculated as log10 ^[TG/HDL-C]. The subjects were divided into four groups on the basis of the quartiles of AIP values at baseline. A multivariable Cox proportional hazards model and a GAM were employed to assess the longitudinal predictive effect of the AIP on the risk of new-onset T2D. The predictive efficacy of the AIP, TG, and HDL-C for new-onset T2D was analyzed and compared via receiver operating characteristic (ROC) curve analysis. Results: A total of 18,295 subjects were selected, of whom 1,300 developed T2D by 2022. After adjusting for confounding factors, we found that the AIP was positively associated with the incidence of T2D. When AIP was categorized into four groups based on quartiles, the risk of new-onset T2D in the 2nd to 4th groups increased by 26% (95% Conclusion: The study demonstrated that the AIP was positively associated with an increased incidence of T2D, suggesting that the AIP should serve as a valuable indicator for monitoring and preventing new-onset T2D.

Indexed as

AtherosclerosisDiabetes Mellitus, Type 2AgedAged, 80 and overBiomarkersChinaCholesterol, HDLFemaleFollow-Up StudiesHumansIncidenceLongitudinal StudiesMaleMiddle AgedRisk FactorsTriglyceridesBiomarkersCholesterol, HDLTriglyceridesatherogenic index of plasma (AIP)Baoan health longitudinal study (BaHLS)elderlylongitudinal studytype 2 diabetes (T2D)

Identifiers

PMID41169472
PMCPMC12568405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.